Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer

Blood Advances(2021)10.1182/bloodadvances.2020003149Source: DataRank Database

Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer is a research paper published in Blood Advances (2021). On theSindex it has a DataRank of 0. It has been cited 66 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access66 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 9.73)OA: goldTopics (29)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Kenison B. Garratt,Anaum Maqsood ORCID,Steven P. Grover ORCID,Tomohiro Kawano ORCID,Brian C. Cooley ORCID

Live enrichment

PubMed:33496742 PMC:PMC7839372 OpenAlex:https://openalex.org/W3121839662

NCI NIH HHS

Grant: R01 CA211098

NHLBI NIH HHS

Grant: T32 HL007149

NHLBI NIH HHS

Grant: R01 HL147149

NHLBI NIH HHS

Grant: U01 HL143403

FWCI

9.73

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1182/bloodadvances.2020003149

publisherhttps://doi.org/10.1182/bloodadvances.2020003149

publisherhttp://ashpublications.org/bloodadvances/article-pdf/5/2/487/1797929/advancesadv2020003149.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33496742

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7839372

Fields of Study

Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsProtease and Inhibitor MechanismsAnimalsDisease Models, AnimalHumansMiceMice, NudePancreatic NeoplasmsPlasminogen Activator Inhibitor 1Venous Thrombosis

MeSH Terms

AnimalsDisease Models, AnimalHumansMice, NudePancreatic NeoplasmsPlasminogen Activator Inhibitor 1Venous ThrombosisMice

Keywords

Venous thrombosisPancreatic cancerMedicinePlasminogen activatorThrombosisPlasminogen activator inhibitor-1Internal medicineCancer researchCancerGastroenterology

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767261.v1figshare

Additional file 1 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767261figshare

Additional file 3 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767267figshare

Additional file 2 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767264.v1figshare

Additional file 4 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767270figshare

Additional file 4 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767270.v1figshare

Additional file 2 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767264figshare

Additional file 3 of Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders

10.6084/m9.figshare.22767267.v1figshare